A role for Pak protein kinases in Schwann cell transformation

被引:75
作者
Tang, Y
Marwaha, S
Rutkowski, JL
Tennekoon, GI
Phillips, PC
Field, J [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Oncol, Philadelphia, PA 19104 USA
关键词
neurofibrosarcoma; neurofibromatosis; Ras; Rac;
D O I
10.1073/pnas.95.9.5139
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by loss of the NF1 gene, is characterized clinically by neurofibromas and more rarely by neurofibrosarcomas. Neurofibromin, the protein encoded by NF1, possesses an intrinsic GTPase accelerating activity for the Ras proto-oncogene. Through this activity, it is a negative regulator of Ras, The Pak protein kinase is a candidate for a downstream signaling protein that mag mediate Ras signals because it is activated by Rac and Cdc42, two small G proteins required for Ras signaling. Here, we use Pak mutants to explore the role of Pak in Ras signaling in Schwann cells, the cells affected in NF1, Whereas an activated Pak mutant does not transform cells, dominant negative Pak mutants are potent inhibitors of Ras transformation of rat Schwann cells and of a neurofibrosarcoma cell line from an NF1 patient. Although activated Pak stimulated jun-N-terminal kinase, inhibition of Ras transformation by dominant negative Pak did not require inhibition of jun-N-terminal kinase, Instead, the Pak mutants appeared to inhibit transformation by preventing Ras activation of the ERK/mitogen-activated protein kinase cascade. These results have implications for our understanding of NF1 because a neurofibrosarcoma cell line derived from a patient with NF1 was reverted by stable expression of the Pak dominant negative mutants.
引用
收藏
页码:5139 / 5144
页数:6
相关论文
共 37 条
[31]   ANGIOGENIC AND INVASIVE PROPERTIES OF NEUROFIBROMA SCHWANN-CELLS [J].
SHEELA, S ;
RICCARDI, VM ;
RATNER, N .
JOURNAL OF CELL BIOLOGY, 1990, 111 (02) :645-653
[32]   THE RAC AND RHO PATHWAYS AS A SOURCE OF DRUG TARGETS FOR RAS-MEDIATED MALIGNANCIES [J].
SYMONS, M .
CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) :668-674
[33]   Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts [J].
Tang, Y ;
Chen, ZX ;
Ambrose, D ;
Liu, JH ;
Gibbs, JB ;
Chernoff, J ;
Field, J .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4454-4464
[34]   DELETIONS AND A TRANSLOCATION INTERRUPT A CLONED GENE AT THE NEUROFIBROMATOSIS TYPE-1 LOCUS [J].
VISKOCHIL, D ;
BUCHBERG, AM ;
XU, GF ;
CAWTHON, RM ;
STEVENS, J ;
WOLFF, RK ;
CULVER, M ;
CAREY, JC ;
COPELAND, NG ;
JENKINS, NA ;
WHITE, R ;
OCONNELL, P .
CELL, 1990, 62 (01) :187-192
[35]   TYPE-1 NEUROFIBROMATOSIS GENE - IDENTIFICATION OF A LARGE TRANSCRIPT DISRUPTED IN 3 NF1 PATIENTS [J].
WALLACE, MR ;
MARCHUK, DA ;
ANDERSEN, LB ;
LETCHER, R ;
ODEH, HM ;
SAULINO, AM ;
FOUNTAIN, JW ;
BRERETON, A ;
NICHOLSON, J ;
MITCHELL, AL ;
BROWNSTEIN, BH ;
COLLINS, FS .
SCIENCE, 1990, 249 (4965) :181-186
[36]   THE CATALYTIC DOMAIN OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT STIMULATES RAS GTPASE AND COMPLEMENTS IRA MUTANTS OF SACCHAROMYCES-CEREVISIAE [J].
XU, GF ;
LIN, B ;
TANAKA, K ;
DUNN, D ;
WOOD, D ;
GESTELAND, R ;
WHITE, R ;
WEISS, R ;
TAMANOI, F .
CELL, 1990, 63 (04) :835-841
[37]  
YAN N, 1995, CANCER RES, V55, P3569